Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Recruitment complete in first stage of TACTT1 study

Aug. 14, 2012

Auris Medical completes enrollment in AM-111 trial

April 24, 2012

Study reveals new therapeutic use for phosphodiesterase 5 inhibitors

Feb. 24, 2012

Pergamum begins phase II DPK-060 trial in outer ear infections

Jan. 17, 2012

JNK inhibitor prevents hearing loss due to transient cochlear ischemia in preclinical study

Jan. 12, 2012

Phage Pharmaceuticals submits IND for first-in-class therapeutic

Dec. 27, 2011

Second milestone reached in GenVec/Novartis collaboration

Dec. 7, 2011

Peptide P-13 ameliorates experimental otitis media

July 14, 2011

Sanofi and Audion Therapeutics to develop treatments for hearing loss

June 17, 2011

Sound Pharmaceuticals begins trial of SPI-1005 for hearing loss induced by loud music

June 8, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...